Skip to main content
. 2014 Dec 1;18(2):260–269. doi: 10.3109/13697137.2014.966241

Table 2.

Summary of Kupperman index and hot flush frequency reported in the studies included in the meta-analysis. Data are given as mean (standard deviation), except for side-effects which are reported as a number

Number of women
Baseline KI
KI after intervention
Baseline hot flush frequency (/day)
Hot flush frequency after intervention (/day)
Side-effect number
Study Placebo Phyto Placebo Phyto Placebo Phyto Placebo Phyto Placebo Phyto Placebo Phyto
Aso15 60 66 2.9 (2.1) 3.2 (2.4) 1.9 (NA)
change from baseline: −1.0 (2.0)
1.3 (NA)
change from baseline: −1.9 (1.8)
Atkinson16 103 102 2.5 (3.0) 2.1 (2.7) 1.5 (2.0)
change from baseline: −1.0 (1.8)
1.2 (2.3)
change from baseline: −0.8 (2.1)
Cancellieri17 65 60 19.6 (8.5) 20.8 (9.1) 12.2 (7.2) 9.6 (5.7)
Del Giorno18 50 50 25.12 (9.02) 25.34 (10.17) 12.01 (9.01) 11.12 (8.68)
Ferrari19 94 82 23.5 (7.1) 23.4 (8.3) 16.1 (7.6) 17.5 (10.0) 7.5 (2.8) 8.0 (3.3) 5.3 (3.8) 4.7 (4.2) 8 6
Han20 40 40 40.3 (7.6) 44.6 (6.3) 41.6 (7.0) 24.9 (10.8)
Lewis11 33 33 4.72 (3.04) 4.08 (2.38) 3.79 (3.00) 3.37 (2.55)
Nahas21 38 38 10.1 (4.9) 9.6 (3.9) 5.9 (4.3) 3.1 (2.3) 4 7
Penotti22 34 28 8.6 (2.9) 9.9 (4.5) 4.0 (3.9) 4.6 (3.8)
Petri Nahas23 25 26 20.05 (6.14) 21.10 (6.11) 13.5 (5.0) 12 (6.0) 6.4 (2.4) 7 (1.8) 5.2 (2.8) 3.0 (2.1) 2 7
Riesco24 21 19 17.0 (9.35) 13.3 (9.9) 15.7 (9.0) 12.3 (9.56)
Sammartino25 36 39 31 (2.5) 31 (3) 26 (1.5) 8 (1)
Tice26 85 167 7.8 (2.35) 8.3 (3.83) 5.0 (3.76) 5.25 (4.17) 33 59
van de Weijer27 14 16 5.75 (5) 5.43 (2.6) 6.04 (5.5) 3.35 (3)
Van Patten28 64 59 7.4 (6.4) 7.1 (4.3) 4.9 (3.9) 5.3 (4.1) 14 28

KI, Kupperman index; Phyto, phytoestrogen; NA, not available

, Mean and standard deviation were estimated from median and range29